At2g17140 Antibody

What is At2g17140 and why is it important in plant research?

At2g17140 refers to a specific gene locus in the Arabidopsis thaliana genome. While the search results don't provide detailed information about this particular gene's function, it appears to be studied in the context of plant development research, particularly in floral tissues. Antibodies targeting this protein are valuable tools for studying its expression patterns, subcellular localization, and potential interactions with other proteins. Understanding At2g17140's function contributes to our knowledge of plant developmental biology, particularly in reproductive structures where protein expression patterns can reveal important functional insights .

What are the recommended storage conditions for At2g17140 antibody?

According to the product information, At2g17140 antibody should be stored at -20°C or -80°C upon receipt. It's important to avoid repeated freeze-thaw cycles as these can degrade the antibody and reduce its efficacy in experimental applications . For working solutions, refrigeration at 4°C is typically suitable for short-term storage (1-2 weeks), while aliquoting and freezing at -20°C is recommended for long-term storage to prevent degradation from repeated freeze-thaw cycles.

What detection methods are compatible with At2g17140 antibody?

Based on research methodologies for plant antibodies, At2g17140 antibody is typically compatible with several detection methods including Western blot analysis, immunofluorescence microscopy, and immunoprecipitation . In Western blot applications, the antibody can detect specific protein bands when used at appropriate dilutions (typically 1:500) with HRP-conjugated secondary antibodies and ECL detection systems. For immunofluorescence, the antibody can be used to visualize the spatial distribution of the target protein in tissue sections, providing insights into its cellular and subcellular localization patterns .

What is the typical dilution range for At2g17140 antibody in Western blot applications?

While the search results don't specify the exact dilution range for At2g17140 antibody specifically, the general protocol for monoclonal antibodies in plant research indicates a typical dilution of 1:500 for Western blot applications . This involves incubating the membrane with the primary antibody overnight at 4°C after blocking with 5% non-fat milk. Following primary antibody incubation, an HRP-conjugated anti-mouse IgG secondary antibody is typically used for detection. Optimal dilution may vary depending on the specific lot and application, and titration experiments are recommended for determining the ideal concentration for your specific experimental conditions.

How can I verify the specificity of At2g17140 antibody in my experiments?

Verifying antibody specificity is crucial for ensuring reliable experimental results. For At2g17140 antibody, several approaches can be employed:

• Western blot analysis: Compare protein extracts from different tissues to determine if the antibody produces a specific band of the expected molecular weight. A single band of the appropriate size suggests specificity .

• Tissue-specific expression analysis: Examine protein expression across different tissues (leaves, stems, inflorescences) to establish if the expression pattern aligns with known biological distribution of the target protein .

• Knockout/knockdown controls: If available, include genetic mutants (knockouts or knockdowns) of At2g17140 as negative controls to confirm the absence or reduction of signal.

• Immunoprecipitation coupled with mass spectrometry: This approach can identify the proteins being recognized by the antibody and confirm target specificity .

• Peptide competition assay: Pre-incubating the antibody with the immunizing peptide should abolish the signal if the antibody is specific.

What protein extraction methods are most effective when working with plant tissues for At2g17140 detection?

Effective protein extraction is essential for successful detection of At2g17140 in plant tissues. The research methodology for generating monoclonal antibodies against Arabidopsis proteins suggests the following approach :

• Tissue collection: Harvest fresh Arabidopsis tissues (inflorescences for floral proteins) and freeze immediately in liquid nitrogen.

• Homogenization: Grind the frozen tissue into a fine powder using a mortar and pestle while maintaining freezing conditions.

• Extraction buffer: Use a protein extraction buffer containing appropriate detergents (e.g., Triton X-100 or SDS), protease inhibitors, and reducing agents to preserve protein integrity.

• Centrifugation: Clear the lysate by centrifugation to remove cellular debris and insoluble material.

• Protein quantification: Determine protein concentration using standard methods (Bradford or BCA assay) to ensure consistent loading for Western blot analysis.

For membrane-associated proteins, additional solubilization steps with specific detergents might be necessary. Optimization of extraction conditions may be required depending on the specific properties of At2g17140.

How can I optimize immunofluorescence protocols for detecting At2g17140 in plant tissue sections?

Optimizing immunofluorescence for detecting At2g17140 in plant tissues requires careful consideration of fixation, embedding, sectioning, and antibody incubation conditions. Based on protocols used in plant antibody research , the following steps are recommended:

• Tissue fixation: Fix freshly collected tissues in an appropriate fixative (e.g., 4% paraformaldehyde) to preserve protein structure while maintaining tissue morphology.

• Embedding and sectioning: Embed fixed tissues in paraffin and create thin sections (typically 5-10 μm) for optimal antibody penetration and microscopic visualization.

• Antigen retrieval: This step may be necessary to expose epitopes masked during fixation. Heat-induced or enzymatic antigen retrieval methods can be employed.

• Blocking: Block with appropriate buffers (e.g., BSA or normal serum) to reduce non-specific binding.

• Antibody incubation: Incubate sections with optimized dilutions of At2g17140 antibody (starting at 1:100-1:500) and appropriate fluorophore-conjugated secondary antibodies.

• Controls: Include negative controls (no primary antibody) and positive controls (tissues known to express the target) to validate specificity.

• Counterstaining: Use DAPI or other nuclear stains to provide contextual cellular information.

• Mounting and imaging: Mount slides with anti-fade medium and image using confocal or fluorescence microscopy.

How can At2g17140 antibody be utilized in immunoprecipitation for identifying protein-protein interactions?

Immunoprecipitation (IP) with At2g17140 antibody can reveal protein-protein interactions and protein complexes. The methodology described in the research on Arabidopsis antibodies provides a framework :

• Protein extraction: Extract proteins under native conditions using mild detergents to preserve protein-protein interactions.

• Pre-clearing: Pre-clear the lysate with protein A beads to reduce non-specific binding.

• Antibody incubation: Incubate the pre-cleared lysate with At2g17140 antibody (typically 1-5 μg) for 2 hours at 4°C.

• Immunoprecipitation: Add protein A-conjugated beads and incubate for another hour to capture antibody-protein complexes.

• Washing: Wash beads thoroughly to remove non-specifically bound proteins.

• Elution: Elute bound proteins using appropriate buffers (SDS sample buffer for Western blot analysis or milder conditions for maintaining activity).

• Analysis: Analyze the immunoprecipitated proteins by Western blot or mass spectrometry to identify interaction partners.

The combination of IP with mass spectrometry analysis has been successfully used to discover target antigens for antibodies in plant research, making it a powerful approach for investigating At2g17140's molecular interactions .

What are the considerations for using At2g17140 antibody in chromatin immunoprecipitation (ChIP) experiments?

If At2g17140 is a DNA-binding protein or associated with chromatin, ChIP experiments can provide valuable insights into its genomic targets. While specific ChIP protocols for At2g17140 antibody aren't detailed in the search results, general considerations include:

• Cross-linking: Optimize formaldehyde cross-linking conditions to capture protein-DNA interactions without excessive cross-linking that could impede antibody access.

• Chromatin fragmentation: Determine optimal sonication conditions to generate DNA fragments of appropriate size (typically 200-500 bp).

• Antibody validation: Verify that the At2g17140 antibody can recognize the cross-linked protein by performing Western blot on cross-linked samples.

• IP conditions: Optimize antibody concentration and incubation conditions specifically for ChIP applications.

• Controls: Include input chromatin controls, IgG negative controls, and positive controls (antibodies against known chromatin-associated proteins) to validate the results.

• Analysis methods: Consider qPCR for targeted analysis of specific genomic regions or ChIP-seq for genome-wide binding profiles.

• Data interpretation: Analyze enrichment patterns in the context of genomic features and gene expression data to derive biological meaning.

How can computational approaches enhance antibody-based research for At2g17140?

Recent advances in computational biology can significantly enhance antibody-based research for At2g17140, as suggested by the active learning approaches for antibody-antigen binding prediction :

• Epitope prediction: Computational tools can predict antigenic determinants of At2g17140, aiding in the design of more specific antibodies or understanding cross-reactivity.

• Structural modeling: Protein structure prediction algorithms can model At2g17140's three-dimensional structure, providing insights into antibody binding sites and functional domains.

• Machine learning for binding prediction: Machine learning models can predict antibody-antigen binding properties, potentially identifying optimal antibody candidates without extensive experimental screening .

• Active learning strategies: These approaches can reduce experimental costs by iteratively selecting the most informative experiments to perform, accelerating the discovery of optimal antibody-antigen pairs .

• Data integration: Combining antibody binding data with transcriptomics, proteomics, and phenotypic data can provide a comprehensive understanding of At2g17140's biological role.

These computational approaches can complement experimental methods, reducing the time and resources required for antibody characterization and application development.

What are common causes of false positives/negatives when using At2g17140 antibody in Western blots?

False results in Western blot experiments with At2g17140 antibody can arise from various sources:

False Positives:

• Cross-reactivity: The antibody may recognize epitopes on proteins other than At2g17140, especially in plants with closely related proteins.

• Insufficient blocking: Inadequate blocking can lead to non-specific binding of the primary or secondary antibody.

• Excessive antibody concentration: Using too much antibody can increase background and non-specific binding.

• Sample degradation: Proteolytic fragments may generate unexpected bands that could be misinterpreted.

False Negatives:

• Inefficient protein extraction: The protein extraction method may not efficiently solubilize At2g17140.

• Epitope masking: Protein folding or post-translational modifications may obscure the epitope recognized by the antibody.

• Protein degradation: The target protein may be degraded during sample preparation.

• Insufficient transfer: Inefficient transfer of proteins to the membrane, particularly for high molecular weight proteins.

• Suboptimal antibody dilution: Using too dilute antibody solutions can result in weak or undetectable signals.

Recommended validation steps include using appropriate positive and negative controls, testing different extraction methods, and optimizing antibody concentration through titration experiments .

How can I address batch-to-batch variability in At2g17140 antibody performance?

Antibody batch variability can significantly impact experimental reproducibility. Strategies to address this issue include:

• Lot testing: Test each new lot against a reference lot using identical samples and protocols to quantify any performance differences.

• Standard curves: Generate standard curves with recombinant proteins or well-characterized samples to calibrate different antibody batches.

• Internal controls: Include consistent internal controls in each experiment to normalize for batch-dependent variations.

• Documentation: Maintain detailed records of antibody lot numbers, performance characteristics, and optimal working dilutions.

• Large-scale purchasing: When possible, purchase larger quantities of a single lot to ensure consistency across multiple experiments.

• Validation panel: Develop a panel of standardized samples that can be used to validate each new antibody batch according to established performance criteria.

• Recombinant alternatives: Consider using recombinant antibodies, which typically show less batch-to-batch variability than hybridoma-derived antibodies.

What strategies can overcome poor signal-to-noise ratio in immunofluorescence with At2g17140 antibody?

Poor signal-to-noise ratio is a common challenge in immunofluorescence microscopy. Based on protocols used in plant immunofluorescence studies , the following strategies can help:

• Fixation optimization: Test different fixatives (paraformaldehyde, glutaraldehyde, or combinations) and fixation times to preserve epitope accessibility while maintaining tissue structure.

• Antigen retrieval: Implement antigen retrieval methods (heat-induced or enzymatic) to expose masked epitopes resulting from fixation.

• Enhanced blocking: Extend blocking time or use alternative blocking agents (BSA, normal serum, casein) to reduce non-specific binding.

• Antibody titration: Determine the optimal antibody concentration that maximizes specific signal while minimizing background.

• Extended washing: Increase the number and duration of washing steps to remove unbound antibodies.

• Signal amplification: Consider using signal amplification systems (tyramide signal amplification, quantum dots) for weak signals.

• Alternative secondary antibodies: Test different secondary antibodies with higher sensitivity or lower background.

• Confocal microscopy: Utilize confocal microscopy to reduce out-of-focus fluorescence and improve signal-to-noise ratio.

• Autofluorescence quenching: Implement methods to reduce plant tissue autofluorescence, such as sodium borohydride treatment or specific filter combinations.

How can At2g17140 antibody contribute to understanding floral development in Arabidopsis?

The At2g17140 antibody can serve as a valuable tool for investigating floral development processes in Arabidopsis thaliana:

• Protein expression mapping: The antibody can be used to track At2g17140 protein expression patterns throughout floral development, revealing spatial and temporal regulation that may correlate with specific developmental events .

• Cell-type specific localization: Immunofluorescence microscopy with the antibody can identify cell types expressing At2g17140, providing insights into its role in tissue differentiation and organ formation .

• Subcellular localization: Determining the subcellular localization of At2g17140 can suggest potential functions (e.g., nuclear localization may indicate transcriptional regulation).

• Protein complex identification: Immunoprecipitation followed by mass spectrometry can identify At2g17140 interaction partners, placing it within molecular networks governing floral development .

• Responses to environmental signals: The antibody can be used to monitor changes in At2g17140 expression or localization in response to environmental cues that affect flowering.

• Genetic pathway analysis: Combining antibody-based detection with genetic mutants can position At2g17140 within known developmental pathways.

The strategic approach of generating monoclonal antibodies against total Arabidopsis inflorescence proteins has already yielded valuable cellular markers for studying floral development, suggesting similar potential for the At2g17140 antibody .

What are the considerations for using At2g17140 antibody in cross-species applications?

When considering the use of At2g17140 antibody in species other than Arabidopsis thaliana, several factors should be evaluated:

• Sequence conservation: Assess the degree of sequence conservation of At2g17140 across species, particularly in the epitope region recognized by the antibody.

• Preliminary testing: Perform Western blot analysis on protein extracts from target species to determine cross-reactivity before investing in more complex experiments.

• Validation strategies: Implement rigorous validation in each new species, including positive and negative controls, correlation with known expression patterns, and genetic knockdowns if available.

• Optimization requirements: Modify extraction methods, antibody concentrations, and incubation conditions to accommodate species-specific differences in protein abundance, tissue composition, and background interference.

• Specificity confirmation: Consider performing immunoprecipitation coupled with mass spectrometry to confirm that the antibody recognizes the expected ortholog in the new species.

• Evolutionary context: Interpret cross-species results in an evolutionary context, recognizing that differences in antibody reactivity might reflect genuine biological divergence rather than technical limitations.

• Alternative approaches: Consider complementary approaches such as epitope tagging of the orthologous gene in the target species if cross-reactivity proves insufficient.

How might advanced antibody design technologies improve future iterations of At2g17140 antibody?

Recent advances in antibody design technologies offer promising avenues for developing improved versions of At2g17140 antibody with enhanced specificity, sensitivity, and versatility:

• De novo antibody design: Computational approaches for precise antibody design, as described in recent research , could generate highly specific antibodies against At2g17140 without prior antibody information.

• Structure-based optimization: If the structure of At2g17140 is known or can be predicted, structure-based antibody engineering can target specific epitopes selected for optimal accessibility and specificity.

• Phage display libraries: High-throughput screening of phage display libraries can identify antibody variants with improved affinity and specificity for At2g17140.

• Recombinant antibody production: Switching to recombinant antibody formats would improve batch-to-batch consistency and allow for easier engineering of desired properties.

• Single-domain antibodies: Developing nanobodies or other single-domain antibodies against At2g17140 could provide better tissue penetration and access to restrictive epitopes.

• Multispecific antibodies: Engineering bispecific or multispecific antibodies could enable simultaneous detection of At2g17140 and interacting partners or related proteins.

• Machine learning integration: Utilizing machine learning approaches for antibody-antigen binding prediction could accelerate the development and optimization of improved At2g17140 antibodies.

The combination of precision molecular design based on atomic-accuracy structure prediction has shown promise in generating antibodies with tailored properties, suggesting a path forward for next-generation At2g17140 antibodies with enhanced research utility .